Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
Preliminary Investigation of Gait Initiation and Falls in Multiple Sclerosis.
The dual task-cost of standing balance affects quality of life in mildly disabled MS people.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Cell fusion in the brain: two cells forward, one cell back.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Restless legs syndrome heralding an acute exacerbation of multiple sclerosis.
Multiple Sclerosis: Does Nogo Play a Role?
Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
LSN MS guidelines for the management of multiple sclerosis.
Experience with Fingolimod in Clinical Practice.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
Pages
« first
‹ previous
…
259
260
261
262
263
264
265
266
267
…
next ›
last »